Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2023-08-16 00:00:00 ET · period of report 2023-08-16 · accession 0001209191-23-046154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-08-16 | 2023-08-16 | TSHA | Manning Paul B | 10% | P - Purchase | $0.9 | +16.47M | 16.47M | New | +$14.82M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-16 | P | A | 16,466,667 | $0.9 | 16,466,667 | I See footnote | — | — | (F1) The change in the total shares held prior to the transactions reported herein reflects a change in form of ownership and, therefore, was not required to be reported pursuant to Section 16. (F2) The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Revocable Trust"). The Reporting Person is the trustee of the Revocable Trust and has sole voting and investment power with respect to the shares held by the Revocable Trust. |